Luís Guimarães-Pereira1,2, Filomena Farinha3, Luís Azevedo4, Fernando Abelha3,5, José Castro-Lopes6. 1. Department of Anesthesiology, Centro Hospitalar São João, Oporto, Portugal. luis.alberto.p@hotmail.com. 2. Department of Health Information and Decision Sciences & Center for Health Technology and Services Research, Faculty of Medicine of the University of Porto, Oporto, Portugal. luis.alberto.p@hotmail.com. 3. Department of Anesthesiology, Centro Hospitalar São João, Oporto, Portugal. 4. Department of Health Information and Decision Sciences & Center for Health Technology and Services Research, Faculty of Medicine of the University of Porto, Oporto, Portugal. 5. Department of Surgery, Faculty of Medicine of the University of Porto, Oporto, Portugal. 6. Department of Experimental Biology, Faculty of Medicine of the University of Porto, Oporto, Portugal.
Abstract
BACKGROUND: Cardiac surgery (CS) ranks among the most frequently performed interventions worldwide and persistent postoperative pain (PPP) has been recognized as a relevant clinical outcome in this context. We aimed to evaluate its incidence, characteristics, associated factors and patient's quality of life (QoL). METHODS: Observational prospective study conducted in patients undergoing CS in a tertiary university hospital. PPP was defined as persistent pain after surgery with higher than 3 months' duration, after excluding other causes of pain. We used a set of questionnaires for data collection: Pain Catastrophizing Scale, Duke Health Profile, Brief Pain Inventory Short Form, McGill Pain Questionnaire Short Form, Douleur Neuropathique en 4 Questions and standardized questions regarding pain periodicity. RESULTS: A total of 288 patients have completed the study and 43% presented PPP assessed at 3 months (PPP3M); out of which 84% were not under any treatment. PPP patients reported significantly lower QoL, and a neuropathic pain (NP) component was present in 50% of them. Younger age, female gender, higher body mass index, catastrophizing, coronary artery bypass graft, osteoarthritis, history of previous surgery (excluding sternotomy) and moderate to severe acute postoperative pain were independent predictors of PPP3M. CONCLUSION: This is the first study comprehensively describing PPP after CS and identifying NP in half of them. Our results support the important role that PPP plays after CS in considering its interference in patients' daily life and their lower QoL, which deserves the attention of health care professionals in order to improve prevention, assessment and treatment of these patients. WHAT DOES THIS STUDY ADD?: This study comprehensively describes persistent postoperative pain (PPP) after cardiac surgery (CS) and identifies neuropathic pain (NP) in half of them. Our results support the important role that PPP plays after CS in considering its interference in patients' daily life and their lower quality of life.
BACKGROUND: Cardiac surgery (CS) ranks among the most frequently performed interventions worldwide and persistent postoperative pain (PPP) has been recognized as a relevant clinical outcome in this context. We aimed to evaluate its incidence, characteristics, associated factors and patient's quality of life (QoL). METHODS: Observational prospective study conducted in patients undergoing CS in a tertiary university hospital. PPP was defined as persistent pain after surgery with higher than 3 months' duration, after excluding other causes of pain. We used a set of questionnaires for data collection: Pain Catastrophizing Scale, Duke Health Profile, Brief Pain Inventory Short Form, McGill Pain Questionnaire Short Form, Douleur Neuropathique en 4 Questions and standardized questions regarding pain periodicity. RESULTS: A total of 288 patients have completed the study and 43% presented PPP assessed at 3 months (PPP3M); out of which 84% were not under any treatment. PPP patients reported significantly lower QoL, and a neuropathic pain (NP) component was present in 50% of them. Younger age, female gender, higher body mass index, catastrophizing, coronary artery bypass graft, osteoarthritis, history of previous surgery (excluding sternotomy) and moderate to severe acute postoperative pain were independent predictors of PPP3M. CONCLUSION: This is the first study comprehensively describing PPP after CS and identifying NP in half of them. Our results support the important role that PPP plays after CS in considering its interference in patients' daily life and their lower QoL, which deserves the attention of health care professionals in order to improve prevention, assessment and treatment of these patients. WHAT DOES THIS STUDY ADD?: This study comprehensively describes persistent postoperative pain (PPP) after cardiac surgery (CS) and identifies neuropathic pain (NP) in half of them. Our results support the important role that PPP plays after CS in considering its interference in patients' daily life and their lower quality of life.
Authors: Saria S Awadalla; Victoria Winslow; Michael S Avidan; Simon Haroutounian; Thomas G Kannampallil Journal: PLoS One Date: 2022-06-10 Impact factor: 3.752
Authors: Marek Zubrzycki; Andreas Liebold; Christian Skrabal; Helmut Reinelt; Mechthild Ziegler; Ewelina Perdas; Maria Zubrzycka Journal: J Pain Res Date: 2018-08-24 Impact factor: 3.133
Authors: Jasvinder A Singh; Celeste A Lemay; Lisa Nobel; Wenyun Yang; Norman Weissman; Kenneth G Saag; Jeroan Allison; Patricia D Franklin Journal: JAMA Netw Open Date: 2019-11-01
Authors: Michael R Boswell; Rajat N Moman; Melissa Burtoft; Harrison Gerdes; Jacob Martinez; Danielle J Gerberi; Erica Wittwer; M Hassan Murad; W Michael Hooten Journal: J Cardiothorac Surg Date: 2021-05-31 Impact factor: 1.637
Authors: Jinying Chen; Jessica G Wijesundara; Angela Patterson; Sarah L Cutrona; Sandra Aiello; David D McManus; M Diane McKee; Bo Wang; Thomas K Houston Journal: BMC Health Serv Res Date: 2021-09-28 Impact factor: 2.908
Authors: Britta C Arends; Leon Timmerman; Lisette M Vernooij; Lisa Verwijmeren; Douwe H Biesma; Eric P A van Dongen; Peter G Noordzij; Heleen J Blussé van Oud-Alblas Journal: BMC Anesthesiol Date: 2022-07-01 Impact factor: 2.376